Novocure (NASDAQ:NVCR)

A non-invasive, portable device that treats glioblastomas with low intensity, alternating electrical fields.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Novocure (NASDAQ:NVCR) plus 5849 other startups.

Learn More

Learn More About Novocure (NASDAQ:NVCR)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With